Biocon Ltd. | BIOCON | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Revenue
Revenue
55,14463,67273,60381,840111,742
Cost of revenue
Cost of revenue
-18,966-20,522-22,085-27,184-36,631
Gross Profit
Gross Profit
36,178
43,150
51,518
54,656
75,111
Sales, general & ad...
Sales, general and administrative
-24,940-30,577-35,954-39,718-53,916
Depreciation
Depreciation and amortization
-4,478-5,522-7,151-8,142-11,131
Provision
Provision
2,6990000
Other op inc/exp...
Other operating income/expenses
003,50700
Operating income
Operating income EBIT
9,459
7,051
11,920
6,796
10,064
 
      
Profit before tax
Profit before tax
12,14012,14911,4699,8318,971
Net Income
Net income
9,053
7,482
7,405
7,716
6,430
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
7.65
6.32
6.24
5.44
3.88